T Cell Immunotherapy – Excellos Cellular Material Helps Boost Development
T cell immunotherapy is a promising and relatively new field of medicine focused on tailoring a person’s own immune cells to fight disease more effectively. The field has enjoyed early success in the area of cancer immunotherapy, most notably the development of chimeric antigen receptor (CAR) T cells designed to express antigens that specifically target […]
Cell and Gene Therapy Industry – Excellos Launches to Accelerate Innovation
Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank Cell and Gene Therapy CDMO San Diego, CA: Excellos, Incorporated, a cell therapy Contract Development and Manufacturing Organization (CDMO), announces its official corporate launch and closing of $15M in growth funding from Telegraph Hill Partners (THP). […]